Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38661805 | 0.90 | MAPT (0.36) | LMNAKMT2AATMKDM4EMEN1 | |
| SCHEMBL9927340 | 0.90 | MAPT (0.36) | LMNAKMT2AATMKDM4EMEN1 | |
| SCHEMBL13203013 | 0.89 | KMT2A (0.41) | LMNAKMT2AATMKDM4EMEN1 | |
| SCHEMBL1610442 | 0.86 | MAPT (0.46) | LMNAKMT2AATMKDM4EMEN1 | |
| SCHEMBL19155781 | 0.86 | DRD2 (0.41) | LMNAHPGDBCHE | |
| Phenoxathiine SCHEMBL28331949 | 0.82 | LMNA (0.48) | LMNAKMT2AATMKDM4EMEN1 | |
| Phenoxathiine SCHEMBL7922 | 0.81 | MAOA (0.42) | KMT2AATMMEN1MAPTTDP1 | |
| Phenoxathiine SCHEMBL29396568 | 0.81 | MAOA (0.42) | KMT2AATMMEN1MAPTTDP1 | |
| Phenoxathiine SCHEMBL29373698 | 0.81 | MAOA (0.42) | KMT2AATMMEN1MAPTTDP1 | |
| SCHEMBL18199790 | 0.79 | AHR (0.47) | LMNAALDH1A1HTTMAPTMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4243782-A | POLYMERIZATION CATALYSTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-01-06 | — | — | US | claimed |
| WO-2024044098-A2 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| US-11217758-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-01-04 | — | — | US | disclosed |
| US-20200321538-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-10-08 | — | — | US | disclosed |
| US-10797246-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-10-06 | — | — | US | disclosed |
| US-10727418-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-28 | — | — | US | disclosed |
| US-20170170405-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
| US-9634260-B2 | Method for preparing conjugated compound having phenoxathiin and electron donating group of conjugated aromatic unit, and OLED device having the conjugated compound | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2017-04-25 | — | — | US | disclosed |
| US-20170054083-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-23 | — | — | US | disclosed |
| US-20160322584-A1 | CONJUGATED COMPOUND HAVING PHENOXATHIINL, METHOD FOR PREPARING THE SAME AND OLED DEVICE | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2016-11-03 | — | — | US | disclosed |
| US-20070089248-A1 | Cosmetic formulations comprising diketo-pyrrolo pyrrole pigments | WALLQUIST OLOF | 2007-04-26 | — | — | US | disclosed |
| US-20070089248-A1 | Cosmetic formulations comprising diketo-pyrrolo pyrrole pigments | WALLQUIST OLOF | 2007-04-26 | — | — | US | disclosed |
| EP-0399293-B1 | PROCESS FOR PREPARING 2-CHLORO-4-NITRO-ALKYLBENZENE | BAYER AG (DE) | 1993-09-01 | — | — | EP | disclosed |
| US-5095157-A | Friedel-crafts catalyst | BAYER AKTIENGESELLSCHAFT (DE) | 1992-03-10 | — | — | US | disclosed |
| EP-0399293-A1 | Process for preparing 2-chloro-4-nitro-alkylbenzene | BAYER AG (DE) | 1990-11-28 | — | — | EP | disclosed |
| EP-0173222-B1 | PROCESS FOR THE NUCLEAR CHLORINATION OF TOLUENE | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-03-09 | — | — | EP | disclosed |
| US-4647709-A | Process for ring-chlorinating toluene | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-03-03 | — | — | US | disclosed |
| EP-0173222-A1 | Process for the nuclear chlorination of toluene | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-03-05 | — | — | EP | disclosed |
| US-4243782-A | POLYMERIZATION CATALYSTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160322584-A1 | CONJUGATED COMPOUND HAVING PHENOXATHIINL, METHOD FOR PREPARING THE SAME AND OLED DEVICE | AOC2, OCIAD2, AOX1 | LMNA 2671/4885KMT2A 1268/4885ATM 3404/4885 |
| US-20070089248-A1 | Cosmetic formulations comprising diketo-pyrrolo pyrrole pigments | TYR, LAGE3, KRT18 | LMNA 2598/4885KMT2A 838/4885ATM 3795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.